You are reading: Healthy Participants | The Airflow Study Part 2

Healthy Participants

The Airflow Study Part 2

Start date

Nov 30th, Dec 07th

Renumeration

$9,925

3 nights + 2 nights + 2 nights, 9 appointments

Help Test a New Treatment for Chronic Obstructive Pulmonary Disease

This clinical study is evaluating a new treatment for Chronic Obstructive Pulmonary Disease, a condition that results in difficulty breathing, wheezing and tiredness. The primary goal is to assess the safety and tolerability of the treatment in healthy adult participants.

Apply Now

Schedule

Participation requires completion of three designated stay periods.
The dates for each period are listed below by cohort.

Cohort 3.1

Period 1

Check In

Nov 30th

Check Out

Dec 03rd

Period 2

Check In

Dec 15th

Check Out

Dec 17th

Period 3

Check In

Dec 29th

Check Out

Dec 31st

9 appointment

Dec 08th, 22nd, Jan 05th, 12th, 26th, Feb 23rd, Mar 23rd, Apr 20th, May 18th

Cohort 3.2

Period 1

Check In

Dec 07th

Check Out

Dec 10th

Period 2

Check In

Dec 22nd

Check Out

Dec 24th

Period 3

Check In

Jan 05th

Check Out

Jan 07th

9 appointment

Dec 15th, 29th, Jan 12th, 19th, Feb 02nd, Mar 02nd, 30th, Apr 27th, May 25th

To Qualify, You Must

Age

Be 18 to 65 years old

Gender

Be a healthy male or female

Physical Condition

NOT have any allergies to food or medications Have NO significant medical conditions

Requirements

Have a BMI between 18 and 32kg/m2

Renumeration

$9,925 *Screening Reimbursement of $100–$250 applies, please see Terms

Help Test a New Treatment for Chronic Obstructive Pulmonary Disease

Spots are limited. Find out if you qualify today!

Apply Now